Cullinan Therapeutics, Inc. (CGEM) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of Cullinan Therapeutics, Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CGEM vs TDOC

growth of $100 · dividends reinvested · last 6y
CGEM -46.4% (-9.9%/yr)TDOC -97.5% (-45.8%/yr)CGEM compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$54$3
CGEM TDOC

CGEM vs TDOC: by the numbers

  • •TDOC is the larger company ($1.05B vs $999M market cap).
  • •Both run net losses; CGEM's is the smaller (0.00% vs -7.13% net margin).

Metrics side by side

Valuation

MetricCGEMTDOC
P/S ratioN/A0.42
P/B ratio3.100.80
EV / EBITDAN/A12.89
FCF yieldN/A21.43%

Profitability

MetricCGEMTDOC
Gross margin0.00%73.53%
Operating margin0.00%-6.98%
Net margin0.00%-7.13%
ROE-63.62%-13.54%
ROIC-68.64%-7.32%

Growth (annualized)

MetricCGEMTDOC
Revenue CAGR (5Y)N/A8.85%
Total return CAGR (5Y)-7.48%-45.85%

Frequently asked

How have CGEM and TDOC total returns compared?
Over the past 5 years, CGEM delivered -7.48% and TDOC delivered -45.85% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.